RFI: NMJ MPS Platforms for BoNT Potency Assay

Request for Information Description

The objective of this RFI is to assess the current landscape of human-relevant neuromuscular junction (NMJ) micro-physiological systems (MPS) and their potential application for botulinum neurotoxin (BoNT) detection, potency measurement, and evaluation of medical countermeasure (MCM) neutralizing activity.

Respondents do not have to be a member of the RRPV consortium to submit a response for this RFI; however, they must be a member of the consortium to respond to any future request for project proposals (RPP) for this requirement.